These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 8293493)
1. Osteoporosis prevention through screening: will it be cost effective? Torgerson DJ; Reid DM Baillieres Clin Rheumatol; 1993 Oct; 7(3):603-22. PubMed ID: 8293493 [No Abstract] [Full Text] [Related]
2. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Torgerson DJ; Donaldson C; Russell IT; Reid DM Eur J Obstet Gynecol Reprod Biol; 1995 Mar; 59(1):57-60. PubMed ID: 7781863 [TBL] [Abstract][Full Text] [Related]
3. Is there a future for non-menopausal screening strategies for osteoporosis prevention? Torgerson DJ Osteoporos Int; 1998; 8 Suppl 1():S57-61. PubMed ID: 9682800 [No Abstract] [Full Text] [Related]
4. Early prevention vs late treatment for osteoporosis. Maricic M Arch Intern Med; 1997 Dec 8-22; 157(22):2545-6. PubMed ID: 9531221 [No Abstract] [Full Text] [Related]
5. Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies. Meadows ES; Stock J; Johnston JA Med Decis Making; 2006; 26(6):633-5; author reply 636-7. PubMed ID: 17099202 [No Abstract] [Full Text] [Related]
6. [Osteoporosis--are screening examinations in the physicians practice useful?]. Minne HW Z Arztl Fortbild (Jena); 1993 Sep; 87(9):737-42. PubMed ID: 8237070 [No Abstract] [Full Text] [Related]
7. Hormone replacement therapy and osteoporosis. Drury R Ir Med J; 1997 Oct; 90(6):214, 216. PubMed ID: 9611918 [No Abstract] [Full Text] [Related]
8. The use of bone mass screening to prevent fractures. Flicker L Med J Aust; 1991 Jan; 154(2):135-40. PubMed ID: 1986192 [No Abstract] [Full Text] [Related]
9. Prevention and screening. Part II: Critical appraisal of articles on screening. Soares I; Carneiro AV Rev Port Cardiol; 2003 Jan; 22(1):117-30. PubMed ID: 12712815 [TBL] [Abstract][Full Text] [Related]
10. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease. Whittington R; Faulds D Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266 [TBL] [Abstract][Full Text] [Related]
11. Results of conference questionnaire to participants on key issues in the prevention of osteoporosis. Allander E Scand J Rheumatol Suppl; 1996; 103():55-62; discussion 63. PubMed ID: 8966491 [TBL] [Abstract][Full Text] [Related]
12. A hard look at hormone replacement. Oates MB; Smith MD; McGhan WF Bus Health; 1997 May; 15(5):48, 50-1. PubMed ID: 10167200 [No Abstract] [Full Text] [Related]
13. Compliance with drug therapies for the treatment and prevention of osteoporosis. McCombs JS; Thiebaud P; McLaughlin-Miley C; Shi J Maturitas; 2004 Jul; 48(3):271-87. PubMed ID: 15207894 [TBL] [Abstract][Full Text] [Related]
15. Estimating the cost per avoided hip fracture by osteoporosis treatment in Italy. Visentin P; Ciravegna R; Fabris F Maturitas; 1997 Apr; 26(3):185-92. PubMed ID: 9147350 [TBL] [Abstract][Full Text] [Related]